In conclusion, pathological stage, number of lymph node metastases, concomitant COPD, postoperative plasma D-dimer, and carcinoembryonic antigen were the risk factors for recurrence within 1 year after radical NSCLC. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.